Cargando…
Therapeutic potential of AMPA receptor antagonist perampanel against cerebral ischemia: beyond epileptic disorder
Autores principales: | Suda, Satoshi, Kimura, Kazumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557096/ https://www.ncbi.nlm.nih.gov/pubmed/31089049 http://dx.doi.org/10.4103/1673-5374.255964 |
Ejemplares similares
-
The AMPA receptor antagonist perampanel suppresses epileptic activity in human focal cortical dysplasia
por: Brito da Silva, Anderson, et al.
Publicado: (2022) -
AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro
por: Lange, Falko, et al.
Publicado: (2019) -
Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel
por: Ettinger, Alan B., et al.
Publicado: (2015) -
Perampanel, a potent AMPA receptor antagonist, protects against tetramethylenedisulfotetramine-induced seizures and lethality in mice: comparison with diazepam
por: Zolkowska, Dorota, et al.
Publicado: (2021) -
PTEN Is Required for The Anti-Epileptic Effects of AMPA Receptor Antagonists in Chronic Epileptic Rats
por: Kim, Ji-Eun, et al.
Publicado: (2020)